Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Dosing begins in phase III palifosfamide study

June 11, 2012

Cancer Research UK opens phase Ib/IIa trial of AstraZeneca drug

June 11, 2012

FDA approves Roche antibody for use in combination cancer therapy

June 11, 2012

MMRF awards funding to Modulation Therapeutics for MTI-101

June 11, 2012

Fluorinov Pharma obtains funding to support development of FV-162

June 11, 2012

New TYK2 inhibitors designed at Cellzome

June 11, 2012

ORCA Therapeutics' lead product set to enter clinic

June 11, 2012

New fatty acid synthase inhibitors patented by GlaxoSmithKline

June 11, 2012

AR-42 gets E.U. orphan drug status for two additional indications

June 8, 2012

Researchers at the CNRS disclose novel inhibitors of tubulin polymerization

June 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....